Sermorelin
GRF(1-29) · GHRH(1-29)NH2 · Geref · Sermorelin acetate
Last updated
At a glance
Overview
Sermorelin has quietly become the default entry point into GH-axis peptides for physique-focused users, recovery-chasers, and anyone trying to recapture the sleep quality and skin turnover of their early 20s. It's a 29-amino-acid fragment of endogenous GHRH — the same signal your hypothalamus uses to tell your pituitary to fire a GH pulse — which means instead of overriding your endocrine system like exogenous HGH does, it just turns the volume up on what your body already does naturally.
That distinction is the whole pitch. A pulsatile, feedback-regulated GH release gives you most of the recovery, sleep, and slow-burn recomp benefits people chase HGH for, without the edema, the GH gut, the insulin resistance creep, or the HPTA-style suppression of your own somatotroph output. It's why the bodybuilding and looksmaxxing community reach for sermorelin for on-cycle joint insurance, off-cycle recovery bridges, and long-run "feel better, sleep harder, age slower" protocols.
"Unlike recombinant GH, sermorelin induces pituitary release of GH in a physiologic, pulsatile manner subject to feedback inhibition." — Walker, Clin Interv Aging (2006)
The catch: sermorelin is not HGH, and people who dose it expecting HGH-tier fat loss and dramatic lean mass come away disappointed. Run with realistic expectations — modest IGF-1 elevation, better sleep architecture, improved recovery, slow skin and body-composition drift over months — and it's one of the cleanest, lowest-risk compounds in the entire peptide space. Below we cover the dosing ladder, the standard ipamorelin stack, fasted-window timing relative to your natural GH pulses, cycle length, side effects, and how sermorelin compares to CJC-1295 and pharmacologic HGH so you can decide where it fits in your protocol.
How Sermorelin works
GHRH Receptor Agonism at the Pituitary#
Sermorelin is the first 29 amino acids of endogenous human GHRH — the minimal sequence that retains full biological activity. It binds the GHRH receptor (GHRHR), a class B G-protein-coupled receptor expressed almost exclusively on anterior-pituitary somatotrophs. Binding activates Gαs → adenylate cyclase → cAMP → PKA, which both triggers exocytosis of pre-formed GH granules and drives transcription of the GH1 gene for sustained output.
"GHRH binds to receptors on pituitary somatotrophs, activates Gs proteins, stimulates adenyl cyclase, and raises intracellular cAMP, resulting in synthesis and secretion of GH." — Mayo KE et al., Recent Prog Horm Res, 1995
Practically: one SC shot produces a discrete GH pulse peaking ~15–30 minutes post-injection. This is the acute event everything downstream — sleep quality, IGF-1, recovery, lipolysis — flows from.
Pulsatile (Not Supraphysiologic) GH Release#
This is the mechanistic fork between sermorelin and exogenous rhGH, and it's the single most important thing to understand about the compound. Sermorelin prompts your own pituitary to release GH in a physiologic pulse. That pulse is still subject to the normal negative-feedback brakes — somatostatin tone, circulating IGF-1, and GH itself — so the system self-limits.
"Unlike recombinant GH, sermorelin induces pituitary release of GH in a physiologic, pulsatile manner subject to feedback inhibition." — Walker RF, Clin Interv Aging, 2006
What this buys you:
- No pituitary suppression — the axis isn't shut down the way endogenous GH production is when you run rhGH.
- No "GH gut," no pharmacologic cartilage/bone remodeling, no supraphysiologic IGF-1 — the ceiling is whatever pulse your own somatotrophs can produce.
- No PCT, no aromatization, no HPTA interaction — layers cleanly onto any AAS cycle, any hair stack, any fat-loss protocol.
The trade-off is honest: you will not see rhGH-level results. What you get is a cleaner, sustainable nudge to the GH/IGF-1 axis.
Downstream IGF-1 Elevation#
Each GH pulse triggers hepatic IGF-1 production. IGF-1 is the workhorse for most of the physique-relevant effects people are chasing — nitrogen retention, collagen synthesis, cartilage/tendon repair, skin quality, and a modest lipolytic signal in adipose tissue. IGF-1 rises slowly across weeks of consistent dosing (it's not a per-injection readout) and plateaus.
"After 16 weeks of treatment, mean serum IGF-I increased by 56% in men and by 98% in women... serum GH concentrations were elevated for 4 h after each injection." — Khorram O et al., J Clin Endocrinol Metab, 1997
A 50–100% IGF-1 bump over baseline at 300 mcg/night is what most users will see by 8–16 weeks. That's meaningful for recovery, sleep architecture, skin/collagen, and joint resilience — the things sermorelin actually delivers — but it's not in the same league as running 4–6 IU of rhGH.
Short Half-Life and Why Timing Matters#
Sermorelin is cleaved rapidly by DPP-IV at the Tyr¹-Ala² bond, giving a brutally short plasma half-life.
"After subcutaneous administration, sermorelin acetate is rapidly absorbed and eliminated, with a mean plasma half-life of 11.7 minutes." — Prakash A, Goa KL, BioDrugs, 1999
This drives every practical dosing rule:
| Timing | Rationale |
|---|---|
| Pre-bed, fasted 2+ hr | Rides the natural nocturnal GH pulse and avoids insulin/somatostatin blunting |
| Post-workout, fasted | Catches a second pulse when endogenous GH is already primed |
| AM fasted | Third pulse window for advanced fat-loss protocols |
| ~100 mcg saturation per shot | Receptor saturates quickly — more frequent dosing beats bigger single shots |
Food — especially carbs — drives an insulin spike that suppresses GH release. This is the single most common reason users think sermorelin "isn't working." The 2-hour fasted window is not optional.
Synergy With Ghrelin-Receptor Agonists (GHRPs)#
Sermorelin works on one arm of GH control (GHRHR → cAMP ↑). Ghrelin-receptor agonists — ipamorelin, GHRP-2, GHRP-6, hexarelin — work on a parallel arm (GHS-R1a → IP3/DAG ↑, plus suppression of somatostatin tone). Hit both at once and you get a GH pulse substantially larger than either alone.
"Combined administration of GHRH and a GHRP results in synergistic increases in serum GH compared to either secretagogue alone." — Bowers CY, J Clin Endocrinol Metab, 2001
This is the mechanistic basis for the canonical sermorelin + ipamorelin stack (typically 300/300 mcg in the same syringe, pre-bed). Ipamorelin is the preferred GHRP partner because it's selective for GHS-R1a and doesn't spike prolactin, cortisol, or hunger the way GHRP-2/6 can. Running sermorelin without a GHRP works — but pairing them is where the compound earns its reputation for sleep depth and next-day recovery.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 200–300 mcg | Once daily | Documented entry-level range |
| Mid | 300–500 mcg | Once daily | Most commonly studied range |
| High | 500–1000 mcg | Once daily | Inject SC pre-bed on an empty stomach (2+ hr fasted window). Split into 2–3 doses/day (fasted AM, post-workout, pre-bed) for fat-loss or advanced recomp protocols. Receptor saturates near ~100 mcg per shot — more frequent dosing beats larger single shots. |
Cycle length & outcomes
Documented cycle
12–24 weeks
Plateau after
24 wks
Cycle Length & Protocol#
Sermorelin isn't a "cycle" compound in the AAS sense — it's a long-run peptide. Because it drives pulsatile, feedback-regulated GH release rather than flooding the system with exogenous hormone, the pituitary doesn't desensitize the way it does to high-dose rhGH, and there's no HPTA to suppress. Most users run it in blocks of 12–24 weeks, often rolling straight into another block after a 2–4 week deload.
Cycle Length by Goal#
| Goal | Cycle Length | Daily Dose | Timing |
|---|---|---|---|
| Sleep & recovery (base protocol) | 12–16 weeks | 200–300 mcg | Pre-bed, 5 nights/week |
| Recomp / skin / anti-aging | 16–24 weeks | 300 mcg | Pre-bed + optional AM fasted dose |
| On-cycle AAS adjunct (joints, sleep) | Duration of AAS cycle | 200–300 mcg ×2 | Post-workout + pre-bed |
| Fat loss (with GHRP) | 8–12 weeks | 300 mcg ×2–3 | Fasted AM, post-workout, pre-bed |
| Post-cycle / bridge | 8–12 weeks | 300 mcg | Pre-bed |
Onset & Timeline#
Sermorelin builds slowly. You're not chasing a single-injection response — you're re-establishing a pattern of nightly GH pulses and letting IGF-1 climb over weeks.
- Week 1–2: sleep depth improves, vivid dreams, mild injection-site flushing that fades
- Week 3–6: recovery between sessions noticeably better, skin quality begins shifting, joints feel lubricated
- Week 6–12: IGF-1 settles at its new baseline (roughly 30–50% above personal baseline at 300 mcg nightly), visceral fat drops modestly, body-composition changes start showing
- Week 12+: diminishing marginal returns — effects plateau rather than compound
"After 16 weeks of treatment, mean serum IGF-I increased by 56% in men and by 98% in women... serum GH concentrations were elevated for 4 h after each injection." — Khorram et al., 1997
That 16-week marker is why the default block is ~16 weeks — it's where the curve flattens.
No Loading, No Tapering#
There is no loading phase and no taper required. Sermorelin reaches its working pattern within the first week of consistent dosing, and stopping produces no rebound, no crash, and no withdrawal — pituitary GH output simply returns to your personal baseline.
"Unlike recombinant GH, sermorelin induces pituitary release of GH in a physiologic, pulsatile manner subject to feedback inhibition." — Walker, 2006
This is the core reason sermorelin is forgiving: the feedback loop is intact. You can miss a night, stop for two weeks, restart — no complex re-entry protocol needed.
Timing Around the GH Pulse#
The single biggest factor separating "this works" from "this does nothing" is fasted-window timing. Sermorelin's half-life is ~12 minutes; the GH pulse it provokes is blunted sharply by circulating insulin and free fatty acids.
"After subcutaneous administration, sermorelin acetate is rapidly absorbed and eliminated, with a mean plasma half-life of 11.7 minutes." — Prakash & Goa, 1999
Practical rules:
- 2+ hours fasted before injection (especially carbs)
- 20–30 minutes fasted after injection — let the pulse complete
- Pre-bed dose rides the natural nocturnal GH pulse that normally peaks ~1 hour after sleep onset — stacking sermorelin on top of this is where most of the recovery benefit comes from
Bloodwork Cadence#
You don't strictly need labs to run sermorelin — but if you're pulling bloods anyway, the community-standard cadence is:
- Baseline: IGF-1, fasting glucose, HbA1c
- Week 6–8: IGF-1 (confirm the bump is in range, not excessive)
- Week 16–20: IGF-1, fasting glucose if running stacked with a GHRP long-term
A dramatic IGF-1 elevation (>100% over baseline) at standard doses suggests you're either hypersensitive, past receptor saturation, or your "sermorelin" is actually CJC-1295 DAC — worth verifying the vial.
Running It Long-Term#
Many users run sermorelin indefinitely at 200–300 mcg pre-bed, 5 nights/week, as a permanent sleep/recovery foundation. At those doses, tachyphylaxis is not a practical concern and IGF-1 stays in a healthy physiologic range. If you want to cycle it off, an 8–12 week off-block every 6 months is more than sufficient — or rotate to CJC-1295 + ipamorelin for variety. There's no mechanistic requirement to stop.
Body Transformation Preview
Lean Mass Gain
1.9 lbs
1.4–2.4 lbs range
Fat Loss
3.8 lbs
2.9–4.8 lbs range
Fat Loss by Week
Risks & mistakes
Common (most users)#
- Injection-site reactions — redness, itch, or a small wheal at the SC site. Benign; rotate sites (abdomen, delt, thigh) and let bac-water reach room temp before injecting.
- Flushing or warmth in the face/neck for 5–15 min post-injection — vasomotor, dose-related, almost always fades after the first 1–2 weeks of consistent use. Back the dose down by 100 mcg if disruptive.
- Mild headache or lightheadedness within the first hour — hydrate, dose pre-bed so you sleep through it, ease in at 200 mcg for the first week.
- Vivid dreams / deeper sleep — reflects increased slow-wave sleep from the nocturnal GH pulse. Usually the most-liked effect, occasionally intrusive; dose earlier in the evening if it keeps you up.
- Transient drowsiness ~20–30 min after injection — lean into it, dose 30–60 min before lights out.
- Mild hunger if stacked with a GHRP (GHRP-2/6) — switch to ipamorelin if it's a problem.
Uncommon (dose-dependent or individual)#
- Water retention / puffiness — driven by the IGF-1 rise, not sermorelin itself. More common at split-dose protocols (2–3×/day) than pre-bed only. Drop frequency or total daily dose.
- Joint aches or mild carpal-tunnel symptoms (wrist numbness, morning hand stiffness) — classic GH-axis signal that you're pushing IGF-1 high. Back off to 200–300 mcg pre-bed only; symptoms resolve within a week or two.
- Transient hypoglycemia — rare on sermorelin monotherapy, more likely when stacked with a GHRP and dosed fasted. Keep carbs nearby; eat if you feel shaky.
- Injection-site lipohypertrophy from not rotating — reshuffle your rotation map.
- Blunted response over time — usually a dosing-hygiene issue (eating too close to injection, stale reconstituted peptide past 30 days, under-dosed vendor) rather than true tachyphylaxis. Audit the protocol before blaming the molecule.
If you're pulling labs, IGF-1 at baseline and 6–8 weeks in is the useful check. A 30–50% bump over personal baseline at 300 mcg nightly is typical and healthy; a massive spike means you're dosing past receptor saturation — spread the dose across more frequent shots instead of larger ones.
"After 16 weeks of treatment, mean serum IGF-I increased by 56% in men and by 98% in women... serum GH concentrations were elevated for 4 h after each injection." — Khorram et al., J Clin Endocrinol Metab (1997)
Rare but serious#
- Hypersensitivity / allergic reaction — hives, swelling, breathing difficulty. Stop immediately and seek care. Reactions to the peptide itself are rare; bac-water benzyl alcohol sensitivity is more common.
- Severe persistent headache with visual changes — stop and get evaluated; pituitary pathology (pre-existing, not caused by sermorelin) can be unmasked by any GH secretagogue.
- Accelerated growth of an undiagnosed tumor — GH and IGF-1 are mitogenic. This is why active malignancy is a hard stop (below), and why anyone with a significant family cancer history should think carefully before running any GH-axis compound long-term.
The sermorelin safety record is genuinely clean — it's been used in pediatric GHD and adult anti-aging settings for decades. Pulsatile, feedback-regulated GH release is a fundamentally safer mechanism than exogenous rhGH.
"Unlike recombinant GH, sermorelin induces pituitary release of GH in a physiologic, pulsatile manner subject to feedback inhibition." — Walker, Clin Interv Aging (2006)
Hard contraindications#
- Active malignancy — do not run sermorelin (or any GH-axis peptide) with a current cancer diagnosis. GH/IGF-1 promotes cell proliferation.
- Pregnancy and breastfeeding — no safety data. Do not use.
- Untreated severe hypothyroidism — blunts the GH response and must be corrected first; running sermorelin on top of uncorrected hypothyroidism is pointless and masks the underlying issue.
- Known hypersensitivity to GHRH, sermorelin, or any excipient (including benzyl alcohol in most bac-water).
- Known pituitary tumor or active Cushing's disease — any somatotroph-stimulating compound is off the table.
Gender considerations and PCT#
Sermorelin is used at the same mcg doses for men and women — dosing is not weight-scaled in practice. Women actually show a larger IGF-1 response than men at equivalent doses (Khorram 1997), so start at 200 mcg pre-bed and titrate.
No PCT required. Sermorelin does not aromatize, does not suppress the HPTA, does not affect LH/FSH, and does not interact with SERMs or hCG. It layers cleanly onto any AAS cycle or PCT protocol, and in fact works well as a bridge compound to preserve sleep quality and lean mass when coming off.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.18 | ×1.15 | ×1.22 |
FAQ — Sermorelin
Where to buy
Swiss Chems
Affiliate link — we may earn a commission at no cost to you.
- Buy Sermorelin, 2mg - SwissChems - Buy Best Quality Peptides, SARMS OnlineBuy Sermorelin
Real Peptides
Affiliate link — we may earn a commission at no cost to you.
- SermorelinBuy Sermorelin
Research & citations
5 studies cited on this page.
Conclusion
Sermorelin is the entry-level GHRH analog that delivers physiologic, pulsatile GH release and a sustainable IGF-1 bump—with a cleaner side-effect profile than anything downstream on the GH/IGF axis.
Key takeaways:
- Typical dose: 200–500 µg subQ pre-bed on an empty stomach (2+ hrs fasted)
- Cycle: 12–24 weeks; longer runs are well-tolerated at moderate doses
- Stacking: Pair with 200–300 µg ipamorelin for synergistic GH output
- Split dosing (AM fasted, post-workout, pre-bed) can enhance fat loss but always fasted
- Expect: improved sleep, recovery, subtly better skin, modest body comp changes—this is not recombinant HGH, but it's reliable for a safer, naturalistic GH pulse
- Side effects: typically mild—local irritation, water retention, vivid dreams; dose reduction handles most issues
If you want sustainable, no-nonsense GH-axis support for recovery, sleep, and mild recomp, sermorelin remains the go-to starter peptide.